Abstract
The dopamine transporter (DAT) has been a primary target for cocaine abuse/addiction medicationdiscovery. However predicted addiction liability and limited clinical evaluation has provided a formidablechallenge for development of these agents for human use. The unique and atypical pharmacological profileof the benztropine (BZT) class of dopamine uptake inhibitors, in preclinical models of cocaine effects andabuse, has encouraged further development of these agents. Moreover, in vivo studies have challenged theoriginal DAT hypothesis and demonstrated that DAT occupancy and subsequent increases in dopamine producedby BZT analogues are significantly delayed and long lasting, as compared to cocaine. These important anddistinctive elements are critical to the lack of abuse liability among BZT analogues, and improve theirpotential for development as treatments for cocaine abuse and possibly other neuropsychiatric disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Science 237:1219
Newman AH (1998) Med Chem Res 8:1
Newman AH, Kulkarni SS (2002) Med Res Rev 22:1
Dutta AK, Zhang S, Kolhatkar R, Reith MEA (2003) Eur J Pharmacol 479:93
Runyon SP, Carroll FI (2006) Curr Top Med Chem 6:1825
Rothman RB, Baumann MH, Prisinzano TE, Newman AH (2008) Biochem Pharmacol 75:2
Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG (1998) Nat Neurosci 1:132
Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR (1998) Proc Natl Acad Sci USA 95:7699
Rothman RB, Greig N, Kim A, De Costa BR, Rice KC, Carroll FI, Pert A (1992) Pharmacol Biochem Behav 43:1135
Vaugeois JM, Bonnet JJ, Duterte-Boucher D, Costentin J (1993) Eur J Pharmacol 230:195
Colpaert FC, Niemegeers CJ, Janssen PA (1979) Biochem Behav 10:535
Husbands SH, Kopajtic T, Izenwasser S, Bowen WD, Vilner BJ, Katz JL, Newman AH (1999) J Med Chem 42:4446
Katz JL, Libby TA, Kopajtic T, Husbands SM, Newman AH (2003) Eur J Pharmacol 468:109
Cao J, Kulkarni SS, Husbands SM, Bowen WD, Williams W, Kopajtic T, Katz JL, George C, Newman AH (2003) J Med Chem 46:2589
Navarro HA, Howard JL, Pollard GT, Carroll FI (2005) Abstract 67th Annual Meeting of the College on Problems of Drug Dependence
Carroll FI (2003) J Med Chem 46:1775
Newman AH, Allen AC, Izenwasser S, Katz JL (1994) J Med Chem 37:2258
Newman AH, Kline RH, Allen AC, Izenwasser S, George C, Katz JL (1995) J Med Chem 38:3933
Kline RH, Izenwasser S, Katz JL, Newman AH (1997) J Med Chem 40:851
Kulkarni SS, Kopajtic TA, Katz JL, Newman AH (2006) Bioorg Med Chem 14:3625
Campbell VC, Kopajtic TA, Newman AH, Katz JL (2005) J Pharmacol Exp Ther 315:631
Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH (1997) J Med Chem 4:4329
Robarge MJ, Agoston GE, Izenwasser S, Kopajtic T, George C, Katz JL, Newman AH (2000) J Med Chem 43:1085
Newman AH, Robarge MJ, Howard IM, Wittkopp SL, Kopajtic T, Izenwasser S, Katz JL (2001) J Med Chem 44:633
Kulkarni SS, Grundt P, Kopajtic T, Katz JL, Newman AH (2004) J Med Chem 47:3388
Agoston GE, Vaughan R, Lever JR, Izenwasser S, Terry PD, Newman AH (1997) Bioorg Med Chem Lett 7:3027
Vaughan RA, Agoston GE, Lever JR, Newman AH (1999) J Neurosci 19:630
Grundt P, Kopajtic TA, Katz JL, Newman AH (2004) Bioorg Med Chem Lett 14:3295
Simoni D, Rossi M, Bertolasi V, Roberti M, Pizzirani D, Rondanin R, Baruchello R, Invidiata PFP, Tolomeo M, Grimaudo S, Merighi S, Varani K, Gessi S, Borea PA, Marino S, Savallini S, Bianchi C, Siniscalchi A (2005) J Med Chem 48:337
Grundt P, Kopajtic T, Katz JL, Newman AH (2005) Bioorg Med Chem Lett 15:5419
Meltzer PC, Liang AY, Madras BK (1994) J Med Chem 37:2001
Meltzer PC, Liang AY, Madras BK (1996) J Med Chem 39:371
Zou MF, Agoston GE, Belov Y, Kopajtic T, Katz JL, Newman AH (2002) Bioorg Med Chem Lett 12:1249
Zou MF, Kopajtic T, Katz JL, Newman AH (2003) J Med Chem 46:2908
Zou MF, Cao J, Kopajtic T, Desai RI, Katz JL, Newman AH (2006) J Med Chem 49:6391
Meltzer PC, Liang AY, Blundell P, Gonzalez MD, Chen Z, George C, Madras B (1997) J Med Chem 40:2661
Meltzer PC, Blundell P, Yong YF, Chen Z, George C, Gonzalez MD, Madras B (2000) J Med Chem 43:2982
Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, Gether U (2008) Mol Pharm 73:813
Kelleher RT (1997) Drug Abuse: the Clinical and Basic Aspects. CV Mosby Co, St. Louis
Izenwasser S, Terry P, Heller B, Witkin JM, Katz JL (1994) Eur J Pharmacol 263:277
Katz JL, Izenwasser S, Newman AH (1997) Pharmacol Biochem Behav 57:505
Katz JL, Izenwasser S, Kline RH, Allen AC, Newman AH (1999) J Pharmacol Exp Ther 288:302
Baker LE, Riddle EE, Saunders RB, Appel JB (1993) Behav Pharmacol 1:69
Kleven MS, Anthony EW, Woolverton WL (1990) J Pharmacol Exp Ther 254:312
Johanson CE, Fischman MW (1989) Pharmacol Rev 41:3
Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, Katz JL (2000) Psychopharmacology 147:426
Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH (2001) Psychopharmacology 154:375
Hodos W (1961) Science 134:943
Gollub L, Yanagita T (1974) Bull Psychon Soc 4:263
Stretch R, Gerber GJ, Lane E (1976) Can J Physiol Pharmacol 54:632
Beardsley PM, Balster RL (1993) Drug Alcohol Depend 34:37
De Beun R, Jansen E, Geerts NE, Slangen JL, Van De Poll NE (1992) Pharmacol Biochem Behav 42:445
Li SM, Newman AH, Katz JL (2005) J Pharmacol Exp Ther 313:1223–1230
Richelson E (1981) Antidepressants: Neurochemical, Behavioral and Clinical Perspectives. Raven Press, New York
McKearney JW (1982) Psychopharmacology 77:156
Tuomisto J, Tuomisto L (1980) Med Biol 58:33
Bergman J, Spealman RD (1986) J Pharmacol Exp Ther 239:104
Scheckel CL, Boff E (1964) Psychopharmacologia 5:198
Tanda G, Ebbs A, Kopajtic T, Campbell B, Newman AH, Katz JL (2007) J Pharmacol Exp Ther 321:332
Tanda G, Katz JL (2007) Pharmacol Biochem Behav 87:400
Katz JL, Kopajtic T, Agoston GE, Newman AH (2004) J Pharmacol Exp Ther 288:302
Ranaldi R, Woolverton WL (2002) Psychopharmacology (Berl) 161:442
Wilson MC, Schuster CR (1973) Pharmacol Biochem Behav 1:643
Raje S, Cao J, Newman AH, Gao H, Eddington N (2003) J Pharmacol Exp Ther 307:801
Othman AA, Syed SA, Newman AH, Eddington ND (2007) J Pharmacol Exp Ther 320:344
Church WH, Justice JB, Byrd LD (1987) Eur J Pharmacol 139:345
Tolliver BK, Ho LB, Newman AH, Fox LM, Katz JL, Berger SP (1999) J Pharmacol Exp Ther 103:110
Tanda G, Ebbs A, Newman AH, Katz JL (2005) J Pharmacol Exp Ther 313:613
Desai R, Kopajtic T, Koffarnus M, Newman AH, Katz JL (2005) J Neurosci 25:1889
Desai R, Kopajtic T, French D, Newman AH, Katz JL (2005) J Pharmacol Exp Ther 315:397
Bergman J, Madras BK, Johnson SE, Spealman RD (1989) J Pharmacol Exp Ther 251:150
Volkow ND, Fowler JS, Wang GJ (2002) Behav Pharmacol 13:355
Reith MEA, Berfield JL, Wang LC, Ferrer JV, Javitch JA (2001) J Biol Chem 276:29012
Chen N, Zhen J, Reith MEA (2004) J Neurochem 89:853
Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kosikowski AP, Pan S, Surratt CK (2005) J Pharmacol Exp Ther 314:575
Vaughan RA, Sakrikar DS, Parnas ML, Foster JD, Duval RA, Lever JR, Kulkarni SS, Newman AH (2007) J Biol Chem 282:8915
Zou M, Kopajtic TA, Katz JL, Wirtz S, Justice JJ, Newman AH (2001) J Med Chem 44:4453
Parnas ML, Gaffaney JD, Zou MF, Lever JR, Newman AH, Vaughan RA (2008) Mol Pharm e-pub Jan 23rd
Loland CJ, Norregaard L, Litman T, Gether U (2002) Proc Natl Acad Sci USA 99:1683
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hauck Newman, A., Katz, J.L. (2008). Atypical Dopamine Uptake Inhibitors that Provide Clues About Cocaine's Mechanism at the Dopamine Transporter. In: Napier, S., Bingham, M. (eds) Transporters as Targets for Drugs. Topics in Medicinal Chemistry, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7355_2008_027
Download citation
DOI: https://doi.org/10.1007/7355_2008_027
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-87911-4
Online ISBN: 978-3-540-87912-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)